Provided by Tiger Trade Technology Pte. Ltd.

Nurix Therapeutics

22.99
-0.3500-1.50%
Post-market: 22.990.00000.00%19:30 EDT
Volume:815.51K
Turnover:18.85M
Market Cap:2.38B
PE:-6.74
High:23.75
Open:23.72
Low:22.85
Close:23.34
52wk High:28.23
52wk Low:8.99
Shares:103.41M
Float Shares:74.11M
Volume Ratio:0.44
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4102
EPS(LYR):-3.0514
ROE:-80.30%
ROA:-40.06%
PB:5.90
PE(LYR):-7.53

Loading ...

Nurix Chief Legal Officer Christine Ring sells 5,394 shares for $90,435

Reuters
·
May 02

Nurix Therapeutics Price Target Maintained With a $32.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 27

Nurix Therapeutics (NRIX) Receives a Buy from Piper Sandler

TIPRANKS
·
Apr 23

Nurix Therapeutics Price Target Maintained With a $26.00/Share by Needham

Dow Jones
·
Apr 23

Nurix reports early clinical NX-1607 target engagement data at AACR 2026

Reuters
·
Apr 22

Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026

GlobeNewswire
·
Apr 22

Nurix Therapeutics (NRIX) Is Up 9.2% After Reporting Sharply Lower Q1 Revenue And Wider Loss

Simply Wall St.
·
Apr 18

Nurix Therapeutics Price Target Maintained With a $32.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 10

Analysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX), Neogen (NEOG) and Nyxoah (NYXH)

TIPRANKS
·
Apr 10

Nurix Therapeutics Inc reports results for the quarter ended February 28 - Earnings Summary

Reuters
·
Apr 10

Nurix Therapeutics price target lowered to $34 from $35 at Stifel

TIPRANKS
·
Apr 09

Nurix Therapeutics Price Target Maintained With a $26.00/Share by Needham

Dow Jones
·
Apr 09

Nurix Therapeutics: Buy Rating Backed by Advancing Bexobrutideg Program, Sanofi STAT6 Milestones, and Solid Cash Runway

TIPRANKS
·
Apr 09

Nurix Therapeutics Shares up 3% After Q1 Results

THOMSON REUTERS
·
Apr 08

Nurix Therapeutics Q1 EPS $(0.79) Beats $(0.86) Estimate, Sales $6.252M Miss $16.607M Estimate

Benzinga Earnings
·
Apr 08

Nurix Therapeutics Shares Trim Premarket Gains After Q1 Results, Last up 3.2%

THOMSON REUTERS
·
Apr 08

Nurix Therapeutics Q1 loss widens on higher costs

Reuters
·
Apr 08

Nurix Therapeutics reports Q1 EPS (79c), consensus (76c)

TIPRANKS
·
Apr 08

Earnings Flash (NRIX) Nurix Therapeutics Posts Fiscal Q1 Loss $0.79 a Share, vs. FactSet Est of $0.76 Loss

MT Newswires Live
·
Apr 08

Nurix FY26 Q1 net loss widens 54.7% to $87.2 million; revenue drops to $6.3 million

Reuters
·
Apr 08